← Insider buys
IONS

Ionis Pharmaceuticals, Inc. · Healthcare

EVP and Chief Scientific Officer C Frank Bennett sold $93K of Ionis Pharmaceuticals, Inc.

Sold$93,337
$49.52Price
1,885Shares
−2%Stake

What IONS did after the filing

Filed Sep 4Copier in Sep 5
The stock from Thu, Sep 5 open, $47.69
−19.3%
S&P 500, same days
+6.0%

Measured over 30 trading days, to the Oct 17 close.

Traded Fri, Feb 2. Filed Wed, Sep 4. Returns use the Sep 5 open and the Oct 17 close. Not investment advice.